DeepLook Medical, specializing in visual enhancement technology for medical imaging, has successfully completed the initial closing of its Series A funding round, led by Xcellerant Ventures with support from OKG Capital.

In conjunction with this achievement, the company has released data highlighting the positive effects of its flagship product, DL Precise™, in improving recall rates at a prominent hospital in metropolitan New York.

In 2024, the hospital's analysis revealed a 12% increase in performance, enabling better compliance with American College of Radiology (ACR) recall rate guidelines.

This advancement is linked to the use of DL Precise™, which also aided in identifying a previously undiagnosed cancer, showcasing its ability to enhance diagnostic accuracy and patient outcomes.

Unlike typical Quality Improvement tools, DL Precise™ operates as a point-of-care intervention integrated into the standard breast imaging workflow, promoting better clinical decisions and quality results.

This information arrives at a critical juncture for mammography centers nationwide, with about 37% currently failing to meet ACR guidelines.

This non-compliance can lead to a 2% decrease in reimbursements from the Centers for Medicare & Medicaid Services (CMS) and private insurers, potentially resulting in annual losses of $50,000 to $200,000 per institution, depending on patient volume.

The findings illustrate the significant impact of DL Precise™ on performance and compliance, demonstrating its ability to boost recall rates and improve cancer detection, ultimately benefiting both healthcare providers and patients.

This is particularly important for patients with dense breast tissue, where visualization poses significant challenges.

The successful initial close of the Series A funding round positions DeepLook Medical for continued growth and innovation. The company plans to use this investment to further commercialize its technology with current and new partners, explore applications in other modalities, and expand its global footprint.




Source: deeplookmedical.com

Report Abuse